Literature DB >> 31779736

Overlooking the transition elephant in the ultra-high-risk room: are we missing functional equivalents of transition to psychosis?

Andrea Raballo1,2, Michele Poletti3.   

Abstract

In the wake of the almost quarter of a century since the conceptualization of ultra-high-risk (UHR) states for psychosis, empirical evidences in the field are constantly scrutinized and re-assessed through meta-analytic lens. Briefly, such scrutiny converges on three major evidences: pretest risk enrichment, risk hierarchy within UHR states, and declining transition rates. While the former two are intuitive, the dilution effect remains elusive and might be rather symptomatic of unsolved issues in the field. Those include the heterogeneously reported antipsychotic (AP) exposure in UHR samples and the almost univocal focus on purely psychometric transition to psychosis. Both issues lead to the neglect of functional equivalents of transition, i.e. that of a mental state at immediate need for AP medication, and might have a cascading confounding effect on the predictive value of contemporary risk calculators centered on criterial transition as a unique outcome.

Entities:  

Keywords:  Antipsychotic; conversion; prediction; psychosis; risk calculation; threshold

Year:  2019        PMID: 31779736     DOI: 10.1017/S0033291719003337

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  4 in total

1.  Antipsychotics are related to psychometric conversion to psychosis in ultra-high-risk youth.

Authors:  Antonio Preti; Andrea Raballo; Anna Meneghelli; Angelo Cocchi; Maria Meliante; Simona Barbera; Lara Malvini; Emiliano Monzani; Mauro Percudani
Journal:  Early Interv Psychiatry       Date:  2021-05-05       Impact factor: 2.721

2.  Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?

Authors:  Andrea Raballo; Michele Poletti; Antonio Preti
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

3.  Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia.

Authors:  Felice Iasevoli; Eugenio Razzino; Benedetta Altavilla; Camilla Avagliano; Annarita Barone; Mariateresa Ciccarelli; Luigi D'Ambrosio; Marta Matrone; Federica Milandri; Danilo Notar Francesco; Michele Fornaro; Andrea de Bartolomeis
Journal:  Early Interv Psychiatry       Date:  2021-05-16       Impact factor: 2.721

4.  What makes the psychosis 'clinical high risk' state risky: psychosis itself or the co-presence of a non-psychotic disorder?

Authors:  Laila Hasmi; Lotta-Katrin Pries; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Gunter Kenis; Alexander Richards; Bochao D Lin; Michael C O'Donovan; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz; Jim van Os
Journal:  Epidemiol Psychiatr Sci       Date:  2021-07-06       Impact factor: 6.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.